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SHORT REPORT
Derivative chromosome 9 deletions in chronic myeloid
leukaemia: interpretation of atypical D-FISH pattern
T S K Wan, S K Ma, W Y Au, L C Chan
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Background/Aims: New molecular cytogenetic tech-
niques are increasingly applied as a routine investigative
tool in haematological malignancies, both at diagnosis
and subsequent monitoring. This report describes the
interpretation of atypical signal patterns encountered using
BCR–ABL dual colour dual fusion fluorescence in situ
hybridisation (D-FISH) translocation probes in chronic
myeloid leukaemia (CML).
Methods: Interphase FISH experiments were carried out
using BCR–ABL D-FISH probes in 46 patients with CML at
diagnosis and during subsequent disease monitoring.
Atypical hybridisation signal patterns were characterised
by molecular cytogenetic techniques and correlated with
conventional karyotyping.
Results: Two patients showed atypical interphase D-FISH
patterns with one orange, one green, and one fusion
(1O1G1F) signal. The presence of BCR–ABL gene fusion
was documented by a dual colour single fusion (S-FISH)
probe. The submicroscopic deletion of the ABL–BCR fusion
gene on the derivative chromosome 9 in these cases was
subsequently characterised by metaphase FISH on
relocated G banded metaphases.
Conclusions: Atypical interphase D-FISH patterns should
not be interpreted in isolation and should be considered in
conjunction with other cytogenetic or molecular genetic
investigations.
The Philadelphia (Ph) chromosome, resulting from thebalanced translocation, t(9;22)(q34;q11.2), which fusesthe 5′ sequences of the BCR gene on chromosome 22 with
3′ sequences of the ABL gene on chromosome 9, is the
diagnostic hallmark of chronic myeloid leukaemia (CML).
This translocation generates two fusion genes, BCR–ABL on
derivative chromosome 22q, known as the Ph chromosome,
and a reciprocal ABL–BCR fusion gene on derivative chromo-
some 9q. The technique of fluorescence in situ hybridisation
(FISH), using probes that bind to specific sequences at the Ph
translocation breakpoints, has been applied extensively at ini-
tial diagnosis of CML to investigate cases with failed
cytogenetics, to detect cryptic BCR–ABL gene fusion, and to
decipher complex Ph rearrangements. The quantification of
BCR-ABL positive cells is achievable through interphase FISH
and hence facilitates the monitoring of disease response to
treatment.
“The Philadelphia chromosome, resulting from the
balanced translocation, t(9;22)(q34;q11.2), is the diag-
nostic hallmark of chronic myeloid leukaemia”
The conventional FISH strategy based on differentially
labelled BCR and ABL probes, which gives a single fusion sig-
nal (S-FISH) and one signal each for the wild-type alleles is
accurate for metaphase analysis, but shows high false positive
value as a result of coincidental juxtaposition of signals. This
drawback severely limits its potential for the detection and
quantification of minimal residual disease, because the
normal cut off point for S-FISH has been set within the 7–10%
range.1 2 To tackle this problem, a dual colour dual fusion
(D-FISH) BCR–ABL probe system has been developed.3 4 These
are large probes, which are designed to span the translocation
breakpoints and are labelled with different fluorochromes. In
addition to one signal each from the normal BCR and ABL
genes, two fusion signals are created in a Ph positive cell: a
BCR–ABL fusion signal on derivative chromosome 22q and an
ABL–BCR fusion signal on derivative chromosome 9q. Variant
signal patterns are encountered in three way Ph translocations
and the addition of an extra Ph chromosome when
investigated by the D-FISH system.5 We describe the molecu-
lar cytogenetic characterisation of two patients with Ph posi-
tive CML, who both showed an identical atypical D-FISH pat-
tern consistent with ABL–BCR deletion, and discuss its




Cytogenetic analysis was performed on Giemsa banded (G
banded) metaphases obtained through short term synchro-
nised and unsynchronised cultures of bone marrow or periph-
eral blood cells based on standardised protocols. Details of the
karyotype were reported in accordance with ISCN 1995.
FISH
Detection of BCR–ABL gene fusion was performed using both
BCR/ABL dual colour single fusion (S-FISH) and BCR/ABL
dual colour dual fusion (D-FISH) translocation probes (Vysis,
Downers Grove, Illinois, USA), according to the manufactur-
er’s instructions. In total, 300 interphase nuclei on cytospin
smears were analysed for the presence of fusion signals. In
addition, metaphase FISH was performed on G banded Ph
positive metaphases relocated using microscope coordinates,
as described previously,6 thereby allowing direct morphologi-
cal correlation of fusion signals and abnormal chromosomes.
Case histories and results
Case 1
A 35 year old Chinese woman presented with a one month
history of weakness and bone pain. Complete blood counts
showed: haemoglobin, 117 g/litre; white blood cell count,
47.0 × 109/litre (neutrophils, 80%; lymphocytes, 13%;metamy-
elocytes, 6%; blasts, 1%), and platelet count 878 × 109/litre. The
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: CML, chronic myeloid leukaemia; D-FISH, dual colour
dual fusion fluorescence in situ hybridisation; FISH, fluorescence in situ
hybridisation; G, Giemsa; Ph, Philadelphia; S-FISH, dual colour single
fusion fluorescence in situ hybridisation
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bone marrow aspirate showed an extremely hypercellular
marrow with hyperplastic granulocytic series. All stages of
myeloid maturation were represented and the blast count
(2%) was within normal limits. However, basophils were
increased (4%). Erythroid activity was relatively preserved and
showed normoblastic maturation. Megakaryocytes were
greatly increased with many small and hypolobulated forms.
A diagnosis of chronic phase CML was made. A cytogenetic
study of the bone marrow cells showed:
46,XX,t(9;22)(q34;q11.2).6
FISH was performed on interphase nuclei using the D-FISH
system. Results showed single orange and green signals,
indicative of normal BCR and ABL alleles, and one fusion sig-
nal in 95% of cells among 300 cells analysed, giving an atypi-
cal 1O1G1F D-FISH pattern. A normal clone (5%) with the
2O2G pattern was present. The presence of the BCR–ABL gene
fusion was confirmed on interphase nuclei using the S-FISH
probe. Deletion of the ABL–BCR reciprocal fusion gene on the
derivative chromosome 9 was further characterised by
metaphase FISH on G banded Ph positive metaphases using
the D-FISH probe.
Case 2
A 79 year old Chinese woman, who was known to have
suffered from CML for 10 years,was investigated for suspected
accelerated phase disease. An initial conventional cytogenetic
study failed to yield metaphases for analysis. Detection of the
BCR–ABL gene fusion was performed on interphase nuclei in
peripheral blood leucocytes using the D-FISH probe. Results
showed single orange and green signals, indicating the
presence of normal BCR and ABL genes, and one fusion signal
(1O1G1F) in 85% of cells among 300 cells analysed (fig 1B). A
Figure 1 Case 2 (A) Complete karyotype showing t(9;22)(q34;q11.2). G banding with trypsin/Giemsa. (B) Interphase fluorescence in situ
hybridisation (FISH) with the dual colour dual fusion (D-FISH) probe, showing one orange, one green, one fusion (yellow) signal, and one
missing fusion signal. (C) Interphase FISH with the dual colour single fusion (S-FISH) probe, showing the presence of BCR–ABL gene fusion
(yellow). (D, E) Metaphase FISH analysis on a relocated G banded chromosome using the D-FISH probe. No ABL–BCR fusion signal is detected
on the derivative chromosome 9 (white arrow).
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normal clone (15%) with a normal D-FISH pattern (2O2G)
was present. The presence of the BCR–ABL fusion gene was
confirmed on interphase nuclei using the S-FISH probe (fig
1C). A repeat cytogenetic study by overnight culture of
peripheral blood cells showed 46,XX,t(9;22)(q34;q11.2)12 (fig
1A). The loss of the ABL–BCR fusion signal on the derivative
chromosome 9 was further characterised by metaphase FISH
on the G banded Ph positive metaphases using the D-FISH
probe as described in case 1 (fig 1D,E).
DISCUSSION
As a result of the generation of two fusion signals and
improved specificity, D-FISH is a useful diagnostic method for
detecting low amounts of BCR–ABL gene fusion in interphase
nuclei. In one study, the mean percentage of false positivity
was 0.25% (SD, 0.39%; range, 0–1.5%) based on the analysis of
200 interphase nuclei.3 When extended to the analysis of 6000
nuclei, the detection limit was improved to 0.079%, making
this technique capable of detecting minimal residual disease.3
With the system that we use, the typical D-FISH pattern in a
BCR–ABL positive interphase cell is one signal each for normal
BCR and ABL alleles and the presence of double fusion signals
(1O1G2F). However, variant D-FISH patterns are produced in
three way Ph translocations, in which the ABL–BCR fusion is
split (2O2G1F), and when there is an extra Ph chromosome
present, in which case three fusion signals would be expected
(1O1G3F). These D-FISH patterns should also be interpreted
as BCR–ABL positive.5
Deletions of the derivative chromosome 9 adjacent to the Ph
translocation breakpoint have recently been recognised in
CML.7 These deletions, found in around 15% of patients with
CML, are large and occur at the time of the Ph translocation.8
Although the deleted segments show considerable heterogen-
eity, they often span the translocation breakpoint, thus
involving the reciprocal ABL–BCR fusion.9 The presence of these
deletions predicts a poor prognosis for those patients with CML
who are undergoing conventional treatment (hydroxyurea or
interferon),8–10 and may be related to the loss of one or more
genes within the deleted region on derivative chromosome 9.10
It is not yet establishedwhether the adverse outcome associated
with derivative chromosome 9 deletions is also applicable to
those patients who are undergoing treatment with imatinib
(STI571). In contrast to the typical D-FISH pattern seen in
BCR–ABL positive cells, these patients show one signal each for
the wild-type BCR and ABL alleles and a single fusion signal
only (1O1G1F) (fig 2). In addition, other derivative chromo-
some 9 deletions involving either deletion of ABL alone
(1O2G1F) or deletion of BCR alone (2O1G1F) can occur.5
“The single fusion signal in the 1O1G1F pattern as
detected by interphase D-FISH, unlike metaphase FISH,
may represent either BCR–ABL or ABL–BCR gene fusion”
A review of our records showed that, of the 46 patients with
CML in whom D-FISH was performed at diagnosis or
subsequent monitoring, two showed an atypical hybridisation
pattern (1O1G1F), indicative of derivative chromosome 9 or
ABL–BCR deletion. Both cases did not show the typical D-FISH
pattern (1O1G2F) in the interphase nuclei, indicating that all
BCR–ABL positive cells harboured the reciprocal ABL–BCR
deletion. The correlation of conventional cytogenetics and met-
aphase FISH results showed that, in accordance with previous
observations,8 9 such deletions were not associated with detect-
able morphological changes on the derivative chromosome 9,
and hence were of a submicroscopic nature. However, we argue
that the single fusion signal in the 1O1G1F pattern as detected
by interphase D-FISH, unlike metaphase FISH, may represent
either BCR–ABL or ABL–BCR gene fusion, and should not be
interpreted as positive in the absence of other supportive
evidence for BCR–ABL gene fusion. Without conventional
cytogenetics or molecular genetics data, the simplest waywould
be to perform S-FISH to confirm the presence of BCR–ABL gene
fusion, as illustrated in the second case.
Figure 2 Signal pattern resulting
from derivative chromosome 9
deletion as detected by dual colour
dual fusion fluorescence in situ
hybridisation (D-FISH). The ABL probe
(chromosome 9) is labelled with an
orange fluorochrome, whereas the
BCR probe (chromosome 22) is
labelled with a green fluorochrome,
with both probes spanning their
respective chromosomal breakpoints.
(A) Typical D-FISH pattern in a
BCR–ABL positive cell, showing one
signal each for the wild-type alleles
and two fusion signals (1O1G2F). (B)
Atypical D-FISH pattern in a BCR–ABL
positive cell with a reciprocal
ABL-BCR deletion, showing one signal
each for the wild-type alleles and one
fusion signal only (1O1G1F).
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In conclusion, although the interphase D-FISH system for
BCR–ABL fusion gene detection shows improved specificity in
minimal residual disease and allows the identification of vari-
ant or atypical patterns, such as derivative chromosome 9
deletions, in clinical practice results should not be taken in
isolation. They should be interpreted in the light of
information gathered through conventional cytogenetics,
FISH, and molecular genetic studies.
. . . . . . . . . . . . . . . . . . . . .
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Take home messages
• The interphase dual colour dual fusion fluorescence in
situ hybridisation (FISH) system can detect the BCR–ABL
fusion gene with improved specificity in minimal
residual disease and can identify variant or atypical
patterns, such as derivative chromosome 9 deletions
• However, in clinical practice results should be
interpreted together with information gathered through
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